Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal Guam.
Press releases published on July 21, 2025
Safety Shot Announces Pricing of $10.6 Million Registered Direct Offering
GlobeNewswire
·
July 21, 2025
SCOTTSDALE, AZ, July 21, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today announced the pricing of a registered direct offering with an institutional investor for …
The Ensign Group Schedules Second Quarter Earnings Call for Friday, July 25, 2025
GlobeNewswire
·
July 21, 2025
SAN JUAN CAPISTRANO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
GlobeNewswire
·
July 21, 2025
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The …
PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 21, 2025
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm Eastern Time. The call …
TELA Bio to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 21, 2025
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report …
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 21, 2025
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will …
Alice L. Walton School of Medicine Hosts Inaugural Class White Coat Ceremony on the Campus of Crystal Bridges Museum of American Art
GlobeNewswire
·
July 21, 2025
Bentonville, Ark., July 21, 2025 (GLOBE NEWSWIRE) -- The inaugural class of 48 students at Alice L. Walton School of Medicine (AWSOM) has embarked on their educational journey at the new medical school in Bentonville. AWSOM is focused on reshaping medical …
Second Circuit Affirms Dismissal of Complaint Against Vystar In the Case Of EMA Financial LLC v. Vystar Corp.
GlobeNewswire
·
July 21, 2025
Boston, MA, July 21, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) On November 27, 2024, the New York federal district court in the case EMA Financial LLC v. Vystar Corp., 19-cv-1545 (GWG) issued a first of its kind court victory for a micro- …
Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight
GlobeNewswire
·
July 21, 2025
New York, USA, July 21, 2025 (GLOBE NEWSWIRE) -- Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight The dynamics of the cutaneous T-cell lymphoma market are …
Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025
GlobeNewswire
·
July 21, 2025
New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant—no needles, no harsh side effects, just sustainable, healthy weight control Natural Appetite Control …
CARBIOS steigt in den Markt für r-PET-Filamente für Reifenverstärkungsgewebe ein
GlobeNewswire
·
July 21, 2025
CARBIOS hat eine mehrjährige kommerzielle Vereinbarung mit Indorama Ventures, dem weltweit führenden Hersteller von Polyester, unterzeichnet. CARBIOS wird in diesem Rahmen recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die …
CARBIOS enters the r-PET market for tire textile filaments
GlobeNewswire
·
July 21, 2025
CARBIOS has signed a multi-year commercial agreement with Indorama Ventures, the world leader in polyester production. CARBIOS will supply recycled monomers that will be transformed into filaments by Indorama Ventures, intended for use in tire …
CARBIOS entre dans le marché du r-PET destiné aux filaments textiles pour pneumatiques
GlobeNewswire
·
July 21, 2025
CARBIOS a signé un engagement commercial pluriannuel avec Indorama Ventures, leader mondial du polyester. CARBIOS fournira les monomères recyclés qui seront transformés en filaments par Indorama Ventures, et destinés au renfort de pneumatiques pour …
REPEAT – Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
GlobeNewswire
·
July 21, 2025
HUNTSVILLE, Ontario, July 21, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, and car cavalcade. Attendees include …
Foundation for Sarcoidosis Research Sarc Fighter Podcast Surpasses 100,000 Downloads, Amplifying Voices in the Sarcoidosis Community
GlobeNewswire
·
July 21, 2025
CHICAGO, July 21, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to celebrate a major milestone for the FSR Sarc Fighter Podcast, which has officially surpassed 100,000 downloads since its launch in 2020. Hosted by John …
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies
GlobeNewswire
·
July 21, 2025
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on …
Acentra Health Names Marnie Keogh as Senior Vice President of Marketing
GlobeNewswire
·
July 21, 2025
MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced …
Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
GlobeNewswire
·
July 21, 2025
WASHINGTON, July 21, 2025 (GLOBE NEWSWIRE) -- Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and implementing immunization programs and strengthening health systems, joins the Sabin Vaccine …
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
GlobeNewswire
·
July 21, 2025
Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells ( …
Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management
GlobeNewswire
·
July 21, 2025
ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced a new patient education destination that empowers …